Wellington Management Group
GILD icon

Wellington Management Group’s Gilead Sciences GILD Stock Holding History

Wellington Management Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-350
Closed -$200K – 2214
2016
Q3 		$200K Buy
+350
New +$28.4K ﹤0.01% 2138

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group's GILD Position: Q2 2026 in Review

Wellington Management Group reduced its Gilead Sciences (GILD) stake by 6.2% in Q2 2026, selling an estimated $110M and leaving 12,699,683 shares worth $1.6B. The position accounts for 0.28% of the portfolio, ranked #85.

Wellington Management Group first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.16B in Q2 2025. 2,281 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Wellington Management Group held 12,699,683 shares of Gilead Sciences worth $1.6B as of Q2 2026.
  • Wellington Management Group sold 838,308 Gilead Sciences shares in Q2 2026, an estimated $110M.
  • Gilead Sciences made up 0.28% of Wellington Management Group's portfolio in Q2 2026, its #85 holding.
  • Wellington Management Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Wellington Management Group's Gilead Sciences position peaked at $4.16B in Q2 2025.
  • 2,281 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.